After a year of progress, scientists say they are on the cusp of turning AI-designed antibodies into potential therapies. In ...

Discover what the next wave of AI-assisted drug discovery looks like and how it can help biotech - the AI and physics combo.

With the advent of AI-powered protein design tools, protein-based therapeutics may no longer be constrained by the limits imposed by natural selection.

A five-city assessment of transit drug use calls for an integrated response that includes naloxone policies, station redesign ...

Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...

The Hotchkiss Model 1886 3-pounder was one of the earliest weapons to demonstrate the potential of true quick-firing artillery. Compact, reliable, and easy to mount on ships of nearly any size, it ...

A new wave of peptides, often banned by the World Anti-Doping Agency, is easily available online, raising concerns about ...

The study introduces a three-circle convergence framework, AI, smart functionality and sustainability, demonstrating that the ...

Researchers at New York University Abu Dhabi (NYUAD) have developed Spheromatrix, a simple and low-cost technology that enables tumor models to be grown, frozen, and stored for future use in cancer ...

Intellicule, a software company founded and led by Purdue University researchers, will use an SBIR Phase I grant from the NIH ...

Researchers at Martin Luther University Halle-Wittenberg (MLU) have developed a promising new substance for targeting ...

A collaborative study, which includes contributions from NDORMS researchers Adam Crowther and supervisor Dario Carugo, ...